Contrast Enhanced Ultrasound Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Equipment, Contrast Agents), By Type (Non-targeted, Targeted), By End use (Hospitals, Clinics, Ambulatory Diagnostic Centers), By Region and Competition, 2020-2030F

December 2025 | 185 pages | ID: CDE0CB40C826EN
TechSci Research

Abstracts

The Global Contrast Enhanced Ultrasound Market, valued at USD 2.27 Billion in 2024, is projected to experience a CAGR of 4.65% to reach USD 2.98 Billion by 2030. Contrast-enhanced ultrasound (CEUS) is a diagnostic imaging modality that utilizes intravenously administered, gas-filled microbubbles to enhance the visualization of blood flow and tissue vascularization during standard medical sonography. This technique improves diagnostic precision by accentuating vascular patterns in organs and lesions, often providing clearer images than conventional ultrasound.

Key Market Drivers

The rising global burden of chronic diseases is a significant market driver for Contrast Enhanced Ultrasound. Conditions like cardiovascular disease, cancer, and hepatic disorders require accurate and frequent diagnostic imaging for early detection, staging, and monitoring treatment. CEUS provides a non-invasive, radiation-free method to precisely assess tissue perfusion and vascularity, which is crucial for characterizing lesions and evaluating organ function. This capability assists clinicians in making timely patient management decisions.

Key Market Challenges

The global scarcity of skilled sonographers poses a significant challenge to the growth of the Contrast Enhanced Ultrasound market. The sophisticated nature of CEUS procedures requires specialized expertise for accurate operation, image acquisition, and interpretation. Without an adequate pool of trained professionals, healthcare facilities face limitations in adopting and fully utilizing this advanced imaging modality, regardless of its diagnostic benefits.

Key Market Trends

AI integration is significantly enhancing contrast-enhanced ultrasound by improving image analysis and diagnostic capabilities. Artificial intelligence algorithms automate segmentation, anomaly detection, and optimize workflow, thereby improving accuracy and efficiency and potentially reducing human error. This technological advance enables faster interpretation of complex images and supports early disease detection, leading to improved patient outcomes. According to Medical Device Network, in July 2023, UltraSight received FDA approval for its AI-based cardiac ultrasound guidance technology, enabling medical professionals without prior sonography experience to capture diagnostic-quality images at the point of care.

Key Market Players

• Lantheus Holdings, Inc.
• General Electric Company
• Siemens Healthineers Company
• nanoPET Pharma GmbH
• ESAOTE SPA
• GE HealthCare Technologies, Inc.
• Koninklijke Philips N.V.
• Leriva SA

Report Scope:

In this report, the Global Contrast Enhanced Ultrasound Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Contrast Enhanced Ultrasound Market, By Product:
• Equipment
• Contrast Agents
• Contrast Enhanced Ultrasound Market, By Type:
• Non-targeted
• Targeted
• Contrast Enhanced Ultrasound Market, By End use:
• Hospitals
• Clinics
• Ambulatory Diagnostic Centers
• Contrast Enhanced Ultrasound Market, By Region:
• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Contrast Enhanced Ultrasound Market.

Available Customizations:

Global Contrast Enhanced Ultrasound Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Contents

1. PRODUCT OVERVIEW

1.1. Market Definition
1.2. Scope of the Market
  1.2.1. Markets Covered
  1.2.2. Years Considered for Study
  1.2.3. Key Market Segmentations

2. RESEARCH METHODOLOGY

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. EXECUTIVE SUMMARY

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. VOICE OF CUSTOMER

5. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET OUTLOOK

5.1. Market Size & Forecast
  5.1.1. By Value
5.2. Market Share & Forecast
  5.2.1. By Product (Equipment, Contrast Agents)
  5.2.2. By Type (Non-targeted, Targeted)
  5.2.3. By End use (Hospitals, Clinics, Ambulatory Diagnostic Centers)
  5.2.4. By Region
  5.2.5. By Company (2024)
5.3. Market Map

6. NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Product
  6.2.2. By Type
  6.2.3. By End use
  6.2.4. By Country
6.3. North America: Country Analysis
  6.3.1. United States Contrast Enhanced Ultrasound Market Outlook
    6.3.1.1. Market Size & Forecast
      6.3.1.1.1. By Value
    6.3.1.2. Market Share & Forecast
      6.3.1.2.1. By Product
      6.3.1.2.2. By Type
      6.3.1.2.3. By End use
  6.3.2. Canada Contrast Enhanced Ultrasound Market Outlook
    6.3.2.1. Market Size & Forecast
      6.3.2.1.1. By Value
    6.3.2.2. Market Share & Forecast
      6.3.2.2.1. By Product
      6.3.2.2.2. By Type
      6.3.2.2.3. By End use
  6.3.3. Mexico Contrast Enhanced Ultrasound Market Outlook
    6.3.3.1. Market Size & Forecast
      6.3.3.1.1. By Value
    6.3.3.2. Market Share & Forecast
      6.3.3.2.1. By Product
      6.3.3.2.2. By Type
      6.3.3.2.3. By End use

7. EUROPE CONTRAST ENHANCED ULTRASOUND MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Product
  7.2.2. By Type
  7.2.3. By End use
  7.2.4. By Country
7.3. Europe: Country Analysis
  7.3.1. Germany Contrast Enhanced Ultrasound Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Product
      7.3.1.2.2. By Type
      7.3.1.2.3. By End use
  7.3.2. France Contrast Enhanced Ultrasound Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Product
      7.3.2.2.2. By Type
      7.3.2.2.3. By End use
  7.3.3. United Kingdom Contrast Enhanced Ultrasound Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Product
      7.3.3.2.2. By Type
      7.3.3.2.3. By End use
  7.3.4. Italy Contrast Enhanced Ultrasound Market Outlook
    7.3.4.1. Market Size & Forecast
      7.3.4.1.1. By Value
    7.3.4.2. Market Share & Forecast
      7.3.4.2.1. By Product
      7.3.4.2.2. By Type
      7.3.4.2.3. By End use
  7.3.5. Spain Contrast Enhanced Ultrasound Market Outlook
    7.3.5.1. Market Size & Forecast
      7.3.5.1.1. By Value
    7.3.5.2. Market Share & Forecast
      7.3.5.2.1. By Product
      7.3.5.2.2. By Type
      7.3.5.2.3. By End use

8. ASIA PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Product
  8.2.2. By Type
  8.2.3. By End use
  8.2.4. By Country
8.3. Asia Pacific: Country Analysis
  8.3.1. China Contrast Enhanced Ultrasound Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Product
      8.3.1.2.2. By Type
      8.3.1.2.3. By End use
  8.3.2. India Contrast Enhanced Ultrasound Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Product
      8.3.2.2.2. By Type
      8.3.2.2.3. By End use
  8.3.3. Japan Contrast Enhanced Ultrasound Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Product
      8.3.3.2.2. By Type
      8.3.3.2.3. By End use
  8.3.4. South Korea Contrast Enhanced Ultrasound Market Outlook
    8.3.4.1. Market Size & Forecast
      8.3.4.1.1. By Value
    8.3.4.2. Market Share & Forecast
      8.3.4.2.1. By Product
      8.3.4.2.2. By Type
      8.3.4.2.3. By End use
  8.3.5. Australia Contrast Enhanced Ultrasound Market Outlook
    8.3.5.1. Market Size & Forecast
      8.3.5.1.1. By Value
    8.3.5.2. Market Share & Forecast
      8.3.5.2.1. By Product
      8.3.5.2.2. By Type
      8.3.5.2.3. By End use

9. MIDDLE EAST & AFRICA CONTRAST ENHANCED ULTRASOUND MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Product
  9.2.2. By Type
  9.2.3. By End use
  9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
  9.3.1. Saudi Arabia Contrast Enhanced Ultrasound Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Product
      9.3.1.2.2. By Type
      9.3.1.2.3. By End use
  9.3.2. UAE Contrast Enhanced Ultrasound Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Product
      9.3.2.2.2. By Type
      9.3.2.2.3. By End use
  9.3.3. South Africa Contrast Enhanced Ultrasound Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Product
      9.3.3.2.2. By Type
      9.3.3.2.3. By End use

10. SOUTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Product
  10.2.2. By Type
  10.2.3. By End use
  10.2.4. By Country
10.3. South America: Country Analysis
  10.3.1. Brazil Contrast Enhanced Ultrasound Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Product
      10.3.1.2.2. By Type
      10.3.1.2.3. By End use
  10.3.2. Colombia Contrast Enhanced Ultrasound Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Product
      10.3.2.2.2. By Type
      10.3.2.2.3. By End use
  10.3.3. Argentina Contrast Enhanced Ultrasound Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Product
      10.3.3.2.2. By Type
      10.3.3.2.3. By End use

11. MARKET DYNAMICS

11.1. Drivers
11.2. Challenges

12. MARKET TRENDS & DEVELOPMENTS

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET: SWOT ANALYSIS

14. PORTER'S FIVE FORCES ANALYSIS

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. COMPETITIVE LANDSCAPE

15.1. Lantheus Holdings, Inc.
  15.1.1. Business Overview
  15.1.2. Products & Services
  15.1.3. Recent Developments
  15.1.4. Key Personnel
  15.1.5. SWOT Analysis
15.2. General Electric Company
15.3. Siemens Healthineers Company
15.4. nanoPET Pharma GmbH
15.5. ESAOTE SPA
15.6. GE HealthCare Technologies, Inc.
15.7. Koninklijke Philips N.V.
15.8. Leriva SA

16. STRATEGIC RECOMMENDATIONS

17. ABOUT US & DISCLAIMER